1. Introduction

Artificial gene-drive governance refers to the legal, scientific, ethical, and institutional framework governing the development, testing, environmental release, monitoring, and potential restriction of genetically engineered organisms designed to spread a particular genetic modification through a population more rapidly than ordinary inheritance would predict.

A gene drive may be developed using CRISPR-based genome editing or other genetic techniques. Its purpose may include suppressing disease-carrying mosquitoes, controlling invasive species, or altering the reproductive capacity of a target population.

Unlike conventional genetic modification, which generally follows ordinary inheritance patterns, a gene drive can increase the likelihood that a particular genetic trait will be inherited. Depending on its design, it may spread through a population and potentially cross geographical boundaries.

The central legal question is therefore:

Who has the authority to authorize, restrict, monitor, or stop a genetically engineered organism capable of spreading beyond the location where it was released?

Artificial gene-drive governance is not, in most jurisdictions, a single, independent body of law. It emerges from the interaction of environmental protection, biosafety, biotechnology regulation, public health, administrative law, international environmental law, property rights, and human rights principles.

2. Meaning and scope of gene-drive governance

A. Scientific and technical governance

Evaluation of genetic stability, inheritance patterns, unintended mutations, resistance, ecological effects, and the possibility of unintended spread.

B. Laboratory and field-trial governance

Containment, research authorization, independent risk assessment, controlled testing, reporting obligations, and emergency response.

C. Environmental and transboundary governance

Assessment of effects on ecosystems, food webs, biodiversity, neighboring jurisdictions, and communities that did not consent to a release.

These dimensions are interconnected. Scientific evidence informs legal risk assessment, while legal institutions determine whether that evidence is sufficient to justify experimentation or release.

3. International legal framework

A. Convention on Biological Diversity, 1992

The Convention on Biological Diversity (CBD) is a foundational international instrument for protecting biodiversity and promoting the sustainable use of biological resources.

Its relevance to gene drives arises from the potential for an engineered organism to affect species, habitats, ecological relationships, and genetic diversity.

The CBD framework supports:

Conservation of biological diversity.

Environmental impact assessment where proposed activities may significantly affect biodiversity.

Cooperation and information-sharing between states.

Consideration of indigenous peoples and local communities whose livelihoods and traditional practices could be affected.

CBD Decision 14/19 (2018), paragraph 11, specifically addresses organisms containing engineered gene drives. It calls for a precautionary approach and says that their introduction into the environment, including experimental releases, should only be considered following scientifically sound, case-by-case risk assessment and appropriate risk-management measures. Where applicable, the prior and informed consent, free, prior and informed consent, or approval and involvement of potentially affected indigenous peoples and local communities should be sought or obtained in accordance with national circumstances and legislation.

Convention on Biological Diversity

+1

The decision is an important governance standard, but it is not itself a universally binding prohibition on all gene-drive research or releases.

B. Cartagena Protocol on Biosafety, 2000

The Cartagena Protocol on Biosafety establishes an international framework for the safe handling, transfer, and use of living modified organisms (LMOs) that may adversely affect biodiversity, taking into account risks to human health.

Its principal governance mechanisms include:

Risk assessment before relevant decisions.

Risk-management measures.

Information exchange through the Biosafety Clearing-House.

Procedures relevant to transboundary movement of covered LMOs.

National decisions concerning import and environmental introduction within the Protocol's scope.

Gene-drive organisms may fall within the Protocol's LMO framework when its legal definitions and other conditions are satisfied. The Protocol's application must be assessed against the organism, proposed activity, and applicable provisions rather than assumed solely from the label “gene drive.” The CBD's dedicated gene-drive resource documents the continuing international work on risk assessment.

Biosafety Clearing-House

+1

C. Precautionary principle

The precautionary principle is central to gene-drive governance because some ecological consequences may be difficult to predict, and a successful environmental release may not be readily reversible.

The principle means that a lack of complete scientific certainty should not automatically justify postponing proportionate measures to prevent serious environmental harm.

In practice, regulators should examine:

The likelihood and severity of possible harm.

The limits of available scientific evidence.

The possibility of unintended spread.

Whether the proposed release can be monitored or contained.

The feasibility of stopping or mitigating adverse effects.

Whether less risky alternatives can achieve the same public-health or environmental objective.

Precaution does not necessarily require a permanent ban. Depending on the evidence and governing law, it may justify additional research, strict containment, delayed authorization, limited trials, or refusal of a proposed release.

4. Indian legal framework

In India, artificial gene-drive governance must be considered under the existing biotechnology and environmental laws. The precise regulatory route depends on the organism, the intended use, and whether the activity remains in a contained facility or involves environmental release.

A. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 provides the central statutory framework for environmental protection and the regulation of potentially hazardous activities.

The Environment (Protection) Rules, 1986, including the rules governing genetically engineered organisms, are relevant to biosafety oversight. The 1989 Rules on the manufacture, use, import, export, and storage of hazardous microorganisms, genetically engineered organisms or cells establish a regulatory framework for covered activities.

Institutions and mechanisms relevant to biotechnology governance include the Review Committee on Genetic Manipulation (RCGM) and the Genetic Engineering Appraisal Committee (GEAC), operating within their respective statutory and administrative roles. GEAC's role is particularly relevant to specified environmental releases and other activities assigned to it under the applicable framework.

PRS Legislative Research

For a gene-drive proposal, the important questions include whether the organism falls within the applicable definitions, which approvals are required, whether environmental-release permission is necessary, and what conditions can be imposed to address ecological risks.

B. Biological Diversity Act, 2002

The Biological Diversity Act, 2002 is relevant where gene-drive research involves biological resources, associated traditional knowledge, access-and-benefit-sharing requirements, or impacts on biodiversity.

It may raise questions about the lawful use of biological resources and the interests of communities connected to those resources. Its particular provisions must be applied according to the activity and the parties involved; it should not be treated as a substitute for the separate biosafety approval regime.

C. Wildlife and environmental protection

The Wildlife (Protection) Act, 1972, the Environment (Protection) Act, 1986, and other applicable environmental laws may become relevant if a proposed gene drive could affect protected species, habitats, or ecological relationships.

A regulator assessing a proposed release should consider not only the intended target species but also foreseeable consequences for non-target organisms, predators, competitors, and ecosystem functions.

D. Institutional accountability

A defensible Indian governance system would require regulators to:

Give scientifically reasoned decisions.

Identify applicable statutory powers and approval requirements.

Consider material ecological evidence.

Provide meaningful opportunities for legally required consultation.

Impose proportionate conditions and monitoring obligations.

Review decisions when significant new evidence emerges.

Provide legally available avenues for administrative or judicial review.

The absence of a gene-drive-specific statute does not automatically mean that gene drives are unregulated. Equally, the existence of general GMO legislation does not answer every question about self-propagating genetic systems.

5. Important case laws and their relevance

A critical distinction is necessary: the leading cases below concern environmental precaution, genetically modified organisms, or regulatory decision-making generally. They are analogous authorities, not judgments directly establishing a comprehensive legal regime for artificial gene drives.

Case 1: Vellore Citizens’ Welfare Forum v. Union of India (1996)

Supreme Court of India · (1996) 5 SCC 647

Facts: The case concerned environmental pollution caused by tanneries discharging untreated effluents, damaging agricultural land and water resources.

Legal principles: The Supreme Court recognized the precautionary principle and polluter-pays principle as essential elements of sustainable development within Indian environmental law. It emphasized anticipatory environmental protection and the need to address serious or irreversible harm despite scientific uncertainty.

Indian Kanoon

+1

Application to gene drives: If a proposed gene-drive release creates a credible risk of irreversible ecological damage, regulators may need to require substantial evidence of safety, impose safeguards, or decline authorization where the governing law supports that outcome.

The case also supports the argument that developers should not automatically be permitted to transfer the costs of environmental damage to affected communities or the public.

Significance: This is a leading Indian authority for applying precautionary reasoning to potentially irreversible environmental interventions.

Case 2: A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

Supreme Court of India · (1999) 2 SCC 718

Facts and issue: The dispute involved environmental clearance for a potentially polluting industry and the evaluation of technical evidence concerning a proposed site.

Legal principles: The Supreme Court discussed the precautionary principle, scientific uncertainty, and the importance of competent scientific assessment in environmental decision-making.

Application to gene drives: Gene-drive decisions involve specialized questions about inheritance, population dynamics, resistance, ecological interactions, and the limits of prediction. The reasoning in Nayudu supports the need for independent scientific expertise and careful evaluation of uncertainty rather than uncritical reliance on an applicant's conclusions.

A regulator should explain how it has evaluated conflicting scientific opinions and why the evidence supports its decision.

Significance: The case is relevant to the quality of scientific reasoning required in complex environmental approvals.

Case 3: Gene Campaign v. Union of India and Aruna Rodrigues v. Union of India (2024)

Supreme Court of India · Judgment and separate opinions dated 23 July 2024

Facts: These proceedings addressed the regulatory approval for environmental release of genetically modified mustard, including the decision-making process and biosafety concerns.

Legal principles: The judges differed on aspects of the approval for GM mustard. The Court's common directions included developing a national policy on GM crops through consultation with relevant stakeholders, scrutiny of experts' credentials and conflicts of interest, and recognition that regulatory decisions concerning GMOs are subject to judicial review. The disagreement on the release approval was referred for consideration by an appropriate bench.

Indian Kanoon

+1

Application to gene drives: This is especially relevant because gene-drive decisions can involve scientific uncertainty, potentially broad ecological consequences, and disagreements between developers, regulators, independent scientists, and affected communities.

The case supports three governance requirements:

Regulatory decisions must be legally reviewable.

Scientific expertise and conflicts of interest require careful scrutiny.

Policy development should include appropriate stakeholder consultation.

Important qualification: GM mustard is not a gene-drive organism. The case does not directly decide whether a gene drive may be released, and the legal status of any particular proposal must be assessed under the applicable legislation and subsequent court orders.

Case 4: M.C. Mehta v. Union of India — Oleum Gas Leak case (1987)

Supreme Court of India · (1987) 1 SCC 395

Facts: The litigation followed a leak of oleum gas from an industrial establishment in Delhi.

Legal principles: The Supreme Court developed the doctrine of absolute liability for enterprises engaged in hazardous or inherently dangerous activities, holding that such enterprises bear a stringent responsibility for harm arising from those activities.

Application to gene drives: The analogy is potentially relevant where a gene-drive activity causes serious environmental or public-health injury. Questions may arise about developer liability, institutional responsibility, compensation, and ecological restoration.

However, absolute liability would not automatically attach to every gene-drive research activity merely because it involves genetic engineering. Its applicability would depend on the nature of the activity, the injury, and the governing legal principles.

Significance: The case provides a framework for examining responsibility for harm caused by hazardous activities, although gene-drive liability remains a distinct and developing legal question.

Case 5: National Environmental Policy Act litigation and environmental review in the United States

US environmental review jurisprudence provides a comparative model for evaluating proposed actions with potentially significant environmental consequences.

The relevant principle is that an agency must comply with the environmental review duties imposed by applicable law, consider the relevant evidence, and provide a reasoned explanation for its decision.

For gene-drive projects, this model raises questions about whether an agency has adequately considered indirect ecological effects, alternatives to release, uncertainty, and possible consequences beyond the immediate test site.

The precise procedural duties depend on the statute governing the particular project; environmental review is not itself a universal prohibition on gene-drive releases.

6. Australian law: an explicit regulatory reference to engineered gene drives

Australia provides a useful comparative example because its Gene Technology Regulations 2001 expressly refer to engineered gene drives.

The Regulations identify as a category that is not a notifiable low-risk dealing certain dealings involving a sexually reproducing genetically modified organism whose offspring are more likely to inherit a particular genetic sequence than offspring of an unmodified parent. They also address certain viral-vector dealings that can produce this effect.

Federal Register of Legislation

+1

This classification is significant because a gene-drive activity cannot simply be treated as an ordinary, low-risk laboratory activity on the basis that the organism is genetically modified.

The Gene Technology Act 2000 establishes the broader statutory framework, including licensing requirements for regulated dealings and a regulatory objective of protecting human health and the environment.

Federal Register of Legislation

Comparative lesson for India: Expressly identifying engineered gene drives in regulatory instruments can reduce uncertainty about classification, licensing, and the level of scrutiny required. The Australian approach is not directly applicable in India, but it illustrates how existing biotechnology legislation can address the distinctive inheritance characteristics of gene drives.

7. Principal legal issues in artificial gene-drive governance

These measures should be proportionate to the particular technology and its risk profile. A contained laboratory experiment and a proposed environmental release of a self-propagating gene drive do not necessarily require identical regulatory treatment.

8. A proposed governance model

The following is a normative model for improving gene-drive governance, rather than a claim that every jurisdiction already requires all these steps.

Stage 1 — Research authorization

Identify the organism, genetic mechanism, proposed purpose, containment requirements, and applicable research permissions.

Stage 2 — Independent risk assessment

Evaluate environmental exposure, unintended spread, ecological interactions, resistance, uncertainty, and possible alternatives.

Stage 3 — Public and community participation

Disclose relevant information, consult affected communities, and apply appropriate consent or approval procedures under the governing law.

Stage 4 — Reasoned authorization decision

Approve, conditionally approve, defer, or refuse the proposal under the applicable legal framework, with written reasons and enforceable safeguards.

Stage 5 — Post-authorization oversight

Require appropriate monitoring, incident reporting, independent review, and predefined responses to unexpected effects.

A key design issue is whether the regulator can intervene effectively after release. Where a genetic modification may propagate through a population, the legal framework should not assume that ordinary product recalls or simple physical containment will necessarily be sufficient.

9. Constitutional and human-rights dimensions in India

Gene-drive governance may also engage constitutional principles, particularly where a proposed release creates risks to public health, livelihoods, biodiversity, or the interests of affected communities.

Article 21: The constitutional protection of life and personal liberty informs judicial consideration of environmental conditions affecting human life and health.

Article 48A: Directs the State to protect and improve the environment and safeguard forests and wildlife.

Article 51A(g): Establishes a fundamental duty of citizens to protect and improve the natural environment.

Article 14: May be relevant where regulatory decisions are arbitrary, discriminatory, or unsupported by a rational legal basis.

These provisions do not independently establish a blanket constitutional prohibition on gene-drive technology. Their significance depends on the particular facts, statutory framework, and grounds of challenge.

10. Critical governance challenges

A. Scientific uncertainty versus public benefit

A gene drive intended to reduce transmission of a serious mosquito-borne disease may offer substantial public-health benefits. Yet its potential ecological effects may extend beyond the immediate objective.

Governance must therefore consider both the consequences of intervention and the consequences of not intervening.

B. Reversibility and accountability

A conventional product can often be withdrawn from circulation. A self-propagating genetic intervention may be much harder to recall after environmental release.

A responsible regulatory decision should assess the limits of reversal mechanisms and avoid treating a proposed reversal strategy as a guarantee of ecological recovery.

C. Consent across borders

A community in one jurisdiction may be affected by an environmental release authorized elsewhere. National approval alone may not resolve the ethical or legal interests of neighboring communities or states.

International notification, information-sharing, and cooperation are therefore important, subject to the applicable treaties and domestic laws.

D. Liability and compensation

Where harm occurs, difficult questions may include whether responsibility rests with the developer, research institution, releasing entity, authorizing authority, or several parties.

A robust system should address causation, evidence preservation, compensation, ecological restoration, and the funding of long-term monitoring. The applicable rules of liability must still be established under the relevant jurisdiction.

11. Conclusion

Artificial gene-drive governance is a developing area at the intersection of biotechnology, environmental law, public health, and administrative accountability.

Three principal legal lessons emerge:

Precaution: Vellore Citizens’ Welfare Forum v. Union of India supports anticipatory environmental protection where serious or irreversible harm is threatened by scientific uncertainty.

Regulatory accountability: Gene Campaign v. Union of India and Aruna Rodrigues v. Union of India demonstrate the importance of judicial review, scientifically informed decision-making, and scrutiny of conflicts of interest in GMO regulation.

Technology-specific regulation: Australia's Gene Technology Regulations 2001 expressly address engineered gene-drive characteristics, illustrating how legislation can distinguish these systems from ordinary low-risk genetic-engineering activities.

At the international level, CBD Decision 14/19 provides a particularly relevant policy framework for precaution, case-by-case assessment, risk management, and community participation.

Convention on Biological Diversity

+2

Final legal position: Gene-drive governance should not depend solely on whether a technology is scientifically promising or whether an ordinary GMO approval pathway exists. It should also consider the potential for propagation, ecological uncertainty, community interests, enforceable monitoring, and the legal accountability of the institutions authorizing and undertaking the activity.

The cases discussed establish relevant environmental and biotechnology principles, but they should not be cited as direct judicial approval or prohibition of gene-drive releases. The legal outcome for any particular proposal will depend on the applicable statute, the quality of the evidence, the nature of the proposed release, and the decision of the competent authority or court.

Selected primary legal sources

Convention on Biological Diversity — Convention text and documents.

Cartagena Protocol on Biosafety — Protocol and biosafety resources.

CBD Decision 14/19 — Synthetic biology and engineered gene-drive considerations.

India's Gene Campaign and Aruna Rodrigues proceedings — Supreme Court decision and directions, 23 July 2024.

Australia's Gene Technology Regulations 2001 — Current published regulatory instrument.